Literature DB >> 7915011

Effect of morphine and abstinence syndrome on [3H]bromoxidine binding to alpha 2-adrenoceptors in rat brain.

A Fernández-López1, C Soria, V Revilla, T Gómez, P Calvo.   

Abstract

At 4 days after the implantation of two subcutaneous 75 mg morphine pellets in the back skin, rats were morphine-dependent. In the three layers studied in the occipital cortex we found that the values of the alpha 2-adrenergic agonist [3H]bromoxidine binding increased with respect to animals implanted with placebo pellets. Typical behavioral and physiological symptoms of the abstinence syndrome appeared 30 minutes after administration of naloxone, [3H]bromoxidine binding values being similar to those obtained in animals implanted with placebo pellets. The pattern of response of the [3H]bromoxidine binding was similar in the hippocampus and the superficial gray layer of the superior colliculus of the mesencephalon, but the differences were not statistically significant in these areas. This paper concludes that exist brain regional differences in the alpha 2-adrenoceptors response under morphine-treatment and possibly under naloxone-induced morphine abstinence syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915011     DOI: 10.1007/bf00967322

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  Loss of recent memory after bilateral hippocampal lesions.

Authors:  W B SCOVILLE; B MILNER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Alpha 2-adrenoceptors in human forebrain: autoradiographic visualization and biochemical parameters using the agonist [3H]UK-14304.

Authors:  A Pazos; A M González; J Pascual; J J Meana; F Barturen; J A García-Sevilla
Journal:  Brain Res       Date:  1988-12-20       Impact factor: 3.252

3.  Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

4.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat.

Authors:  B C Yoburn; J Chen; T Huang; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

5.  Biochemical correlates of morphine withdrawal. 1. Characterization in the adrenal medulla and locus ceruleus.

Authors:  P S DiStefano; O M Brown
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

6.  Differences in the effects of morphine on the alpha-methyl-p-tyrosine-induced depletion of dopamine and noradrenaline in various areas of the mouse brain.

Authors:  L Martti; J Attila; E Etemadzadeh; L Ahtee
Journal:  Pharmacol Toxicol       Date:  1987-07

7.  Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.

Authors:  L M Attila; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

8.  Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.

Authors:  I Ulibarri; J A García-Sevilla; L Ugedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

9.  Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin.

Authors:  J Camí; S de Torres; L San; A Solé; D Guerra; B Ugena
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

10.  Biochemical correlates of morphine withdrawal. 2. Effects of clonidine.

Authors:  P S DiStefano; O M Brown
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.